Gainers
- Gelteq (NASDAQ:GELS) stock increased by 150.7% to $1.29 during Thursday's regular session. The company's market cap stands at $5.5 million.
- Propanc Biopharma (NASDAQ:PPCB) stock increased by 134.07% to $3.16. The market value of their outstanding shares is at $3.0 million.
- Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 43.98% to $3.11. The market value of their outstanding shares is at $4.6 million.
- Theriva Biologics (AMEX:TOVX) shares moved upwards by 37.33% to $0.33. The company's market cap stands at $11.1 million.
- Indaptus Therapeutics (NASDAQ:INDP) shares rose 31.42% to $3.22. The market value of their outstanding shares is at $277.4 million.
- Rafael Holdings (NYSE:RFL) shares increased by 19.1% to $2.12. The company's market cap stands at $92.5 million. As per the press release, Q3 earnings came out today.
Losers
- Atossa Therapeutics (NASDAQ:ATOS) shares decreased by 42.2% to $2.54 during Thursday's regular session. The company's market cap stands at $37.8 million.
- Purple Biotech (NASDAQ:PPBT) shares decreased by 34.46% to $1.94. The market value of their outstanding shares is at $2.7 million.
- Aditxt (NASDAQ:ADTX) shares decreased by 27.03% to $0.01.
- Humacyte (NASDAQ:HUMA) shares fell 24.26% to $1.01. The company's market cap stands at $297.5 million.
- BGM Group (NASDAQ:BGM) stock declined by 19.21% to $0.34. The company's market cap stands at $85.2 million.
- Valion Bio (NASDAQ:VBIO) stock decreased by 17.91% to $0.65. The market value of their outstanding shares is at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment